RIG-I Is Required for the Inhibition of Measles Virus by Retinoids

by Soye, Kaitlin J., Trottier, Claire, Richardson, Chris D., Ward, Brian J., Miller, Wilson H.
Published 2011

Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells

by Petruccelli, Luca A., Dupéré-Richer, Daphné, Pettersson, Filippa, Retrouvey, Hélène, Skoulikas, Sophia, Miller, Wilson H.
Published 2011

Arsenic Trioxide Overcomes Rapamycin-Induced Feedback Activation of AKT and ERK Signaling to Enhance the Anti-Tumor Effects in Breast Cancer

by Guilbert, Cynthia, Annis, Matthew G., Dong, Zhifeng, Siegel, Peter M., Miller, Wilson H., Mann, Koren K.
Published 2013

Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter

by Witcher, Michael, Pettersson, Filippa, Dupéré-Richer, Daphne, Padovani, Alessandra, Summers-Deluca, Leslie, Baldwin, Albert S., Miller, Wilson H.
Published 2008

Resistance to Cancer Treatment: The Role of Somatic Genetic Events and the Challenges for Targeted Therapies

by Batist, Gerald, Wu, Jian Hui, Spatz, Alan, Miller, Wilson H., Cocolakis, Eftihia, Rousseau, Caroline, Diaz, Zuanel, Ferrario, Cristiano, Basik, Mark
Published 2011

In vitro inhibition of mumps virus by retinoids

by Soye, Kaitlin J, Trottier, Claire, Di Lenardo, Thomas Z, Restori, Katherine H, Reichman, Lee, Miller, Wilson H, Ward, Brian J
Published 2013

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer

by Ferrario, Cristiano, Strepponi, Ivan, Esfahani, Khashayar, Charamis, Helen, Langleben, Adrian, Scarpi, Emanuela, Nanni, Oriana, Miller, Wilson H., Panasci, Lawrence C.
Published 2016

High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial

by Hoffer, L. John, Robitaille, Line, Zakarian, Robert, Melnychuk, David, Kavan, Petr, Agulnik, Jason, Cohen, Victor, Small, David, Miller, Wilson H.
Published 2015

In vivo analysis of the role of aberrant histone deacetylase recruitment and RARα blockade in the pathogenesis of acute promyelocytic leukemia

by Matsushita, Hiromichi, Scaglioni, Pier Paolo, Bhaumik, Mantu, Rego, Eduardo M., Cai, Lu Fan, Majid, Samia M., Miyachi, Hayato, Kakizuka, Akira, Miller, Wilson H., Pandolfi, Pier Paolo
Published 2006

Systemic cancer therapy: achievements and challenges that lie ahead

by Palumbo, Michael O., Kavan, Petr, Miller, Wilson H., Panasci, Lawrence, Assouline, Sarit, Johnson, Nathalie, Cohen, Victor, Patenaude, Francois, Pollak, Michael, Jagoe, R. Thomas, Batist, Gerald
Published 2013

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient

by Nielsen, Torsten H., Johnson, Nathalie, Garnier, Nicolas, Kwan, Stanley, Yao, Lu, Cocolakis, Eftihia, Hébert, Josée, Morgan, Robert A., Paquet, Éric, Callahan, Kevin P., Jordan, Craig T., Assouline, Sarit, Miller, Wilson H., Mann, Koren K.
Published 2013

Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study

by Bhatia, Shailender, Curti, Brendan, Ernstoff, Marc S, Gordon, Michael, Heath, Elisabeth I, Miller, Wilson H, Puzanov, Igor, Quinn, David I, Flaig, Thomas W, VanVeldhuizen, Peter, Byrnes-Blake, Kelly, Freeman, Jeremy A, Bittner, Rachel, Hunder, Naomi, Souza, Sonia, Thompson, John A
Published 2014

Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3

by Robichaud, Nathaniel, del Rincon, Sonia V., Huor, Bonnie, Alain, Tommy, Petruccelli, Andy, Hearnden, Jaclyn, Goncalves, Christophe, Grotegut, Stefan, Spruck, Charles H., Furic, Luc, Larsson, Ola, Miller, Wilson H., Sonenberg, Nahum
Published 2014

From Solo in the Silo to Strategic Training Programs

by Koritzinsky, Marianne, Koch, C. Anne, Riley, Barbara, Beauchemin, Nicole, Johnston, Gerry, Johnston, Michael, Koropatnick, James, Loiselle, Carmen G., Maslowska, Magdalena, McCormick, Craig, Miller, Wilson H., Mulligan, Lois, Tsao, Ming-Sound
Published 2016

Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-depende...

by Kefford, Richard, Sullivan, Ryan J, Miller, Wilson H, Elez, Elena M, Tan, Daniel, Kim, Kevin B, Long, Georgina V, Flaherty, Keith T, Tai, David, Stutvoet, Simone, Maacke, Heiko, Whiley, Matt, Parseval, Laure Moutouh-de, Tabernero, Josep
Published 2014

Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase...

by Amin, Asim, Dudek, Arkadiusz Z, Logan, Theodore F, Lance, Raymond S, Holzbeierlein, Jeffrey M, Knox, Jennifer J, Master, Viraj A, Pal, Sumanta K, Miller, Wilson H, Karsh, Lawrence I, Tcherepanova, Irina Y, DeBenedette, Mark A, Williams, W Lee, Plessinger, Douglas C, Nicolette, Charles A, Figlin, Robert A
Published 2015

The sonic hedgehog factor Gli1 imparts drug resistance through inducible glucuronidation

by Zahreddine, Hiba Ahmad, Culjkovic-Kraljacic, Biljana, Assouline, Sarit, Gendron, Patrick, Romeo, Andrea A., Morris, Stephen J., Cormack, Gregory, Jaquith, James B., Cerchietti, Leandro, Cocolakis, Eftihia, Amri, Abdellatif, Bergeron, Julie, Leber, Brian, Becker, Michael W., Pei, Shanshan, Jordan, Craig T., Miller, Wilson H., Borden, Katherine L.B.
Published 2014